Revista Alergia México (May 2016)

Cancer as secondary immunodeficiency. Review

  • María Eugenia Vargas-Camaño,
  • Ricardo Leopoldo Guido-Bayardo,
  • Nora Ernestina Martínez-Aguilar,
  • María Isabel Castrejón-Vázquez

DOI
https://doi.org/10.29262/ram.v63i2.176
Journal volume & issue
Vol. 63, no. 2
pp. 169 – 179

Abstract

Read online

The secondary immunodeficiency’s, previously presented in immunocompetent individuals. The lack of primary or secondary response to the presence of a foreign antigen, in the case of infections is a sentinel data in the diagnosis of immunodeficiency (can be primary or secondary), in the case of a self antigen may generate the presence of Cancer. Cancer has shown an increase in the prevalence and incidence globally. Most current medical treatments in cancer are focused primarily on immunomodulatory actions (immunosuppression / immune stimulation or both). Knowledge of key concepts from the perspective of innate and acquired immunity lead to cancer development, engaging immune surveillance and escape mechanisms of this that contribute to better understand the origin, behavior and treatment of neoplasm’s. These treatments can cause immunological disorders such as allergy, anaphylaxis, lack of response immunogenicity care fields specialist in Allergy and Clinical Immunology.

Keywords